1. Jeong SH. Current status and vaccine indication for hepatitis A virus infection in Korea. Korean J Gastroenterol 2008;51:331-337. 18604134.
2. Sjogren MH, Hepatitis A. In: Feldman M, Friedman LS, Brandt LJ, Sleisenger MH, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 2006. Vol 2: 8th ed. Saunders; p. 1639-1644.
3. Jeong SH, Lee HS. Hepatitis A: clinical manifestations and management. Intervirology 2010;53:15-19. 20068336.
4. Jung KM, Cho YK, Cho JW, Park SH, Kim IH, Choi CS, et al. Clinical features of cholestatic hepatitis with acute viral hepatitis A in Chunbuk province of Korea: Multicenter experience[Abstract]. Korean J Hepatol 2009;15(S3):S175.
5. Coppola N, Genovese D, Pisaturo M, Taffon S, Argentini C, Pasquale G, et al. Acute hepatitis with severe cholestasis and prolonged clinical course due to hepatitis A virus Ia and Ib coinfection. Clin Infect Dis 2007;44:e73-e77. 17407028.
6. Trauner M, Fickert P, Stauber RE. Inflammation-induced cholestasis. J Gastroenterol Hepatol 1999;14:946-959. 10530489.
7. Wolkoff AW. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson HL, eds. The hyperbilirubinemias. Harrison's principles of internal medicine. 2008. Vol II: 17th ed. Mc Graw Hill; p. 1927-1931.
8. Roelofsen H, Schoemaker B, Bakker C, Ottenhoff R, Jansen PL, Elferink RP. Impaired hepatocanalicular organic anion transport in endotoxemic rats. Am J Physiol 1995;269:G427-G434. 7573454.
9. Kauffmann HM, Schrenk D. Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene. Biochem Biophys Res Commun 1998;245:325-331. 9571149.
10. Demeule M, Jodoin J, Beaulieu E, Brossard M, Beliveau R. Dexamethasone modulation of multidrug transporters in normal tissues. FEBS Lett 1999;442:208-214. 9929003.
11. Sherlock S. In: Sherlock S, Dooley J, eds. Viral Hepatitis; General Features, Hepatitis A, Hepatitis E and Other Viruses. Diseases of the Liver and Biliary System. 2002. Oxford: Blackwell Scientific; p. 272-276.
12. Ware AJ, Cuthbert JA, Shorey J, Gurian LE, Eigenbrodt EH, Combes B. A prospective trial of steroid therapy in severe viral hepatitis. The prognostic significance of bridging necrosis. Gastroenterology 1981;80:219-224. 7004995.
13. Schiff ER. Atypical clinical manifestations of hepatitis A. Vaccine 1992;10(Supple 1):S18-S20. 1475999.
14. Dienstag J. In: Bircher J, McIntyre N, Rizzetto M, Rodes J, eds. Hepatitis A. Oxford Textbook of Clinical Hepatology. 1999. 2nd ed. Oxford: Oxford University Press; p. 870-875.
15. Seo YS, Lee KG, Jung ES, An H, Park S, Keum B, et al. Dynamic changes in liver stiffness during the course of acute hepatitis A. Scand J Gastroenterol 2010;45:449-456. 20059404.
16. Kim JH, Yim HJ, Kim SY, Ahn JH, Jung YK, Joo MK, et al. Changes in liver stiffness after acute or chronic liver injury due to viral hepatitisdoes fibrosis exist after recovery from acute viral hepatitis? Korean J Gastroenterol 2009;54:155-161. 19844151.
17. Arena U, Vizzutti F, Corti G, Ambu S, Stasi C, Bresci S, et al. Acute viral hepatitis increases liver stiffness values measured by transient elastography. Hepatology 2008;47:380-384. 18095306.